Established in 1911, Lavipharm is today an integrated Group engaged in Research and Development, Marketing and Sales, Distribution and Wholesaling of pharmaceutical, cosmetic and healthcare products in Greece, with a strong international activity. A pioneer in the area of pharmaceutical technology, Lavipharm develops new dynamic strategies that are flexible in the constantly evolving international environment, but are always in line with its vision with the aim the improvement of quality of life.
| Website | http://www.lavipharm.com |
| Revenue | $8.3 million |
| Employees | 221 (159 on RocketReach) |
| Founded | 1911 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Transdermal Drug Delivery Systems, Dermocosmetics |
| Web Rank | 16 Million |
| Keywords | Pharmaceutical Products, Healthcare Products, Healthcare, Cosmetic Products, Medical Products, Health And Beauty, Cosmetics, Personal Care, Research And Development, Beauty Products, Drug Development, Pharmaceutical Sales, Marketing And Sales, Drug Distribution, Product Marketing, Distribution, Wholesaling, Sales Distribution, Wholesale Distribution |
| Competitors | Roche, Novartis, Pfizer, GSK, Bristol Myers Squibb, Amgen, Sandoz, Actavis plc (now Allergan), Teva Pharmaceuticals USA, Inc., Mylan Belgium +42 more (view full list) |
Looking for a particular Lavipharm employee's phone or email?
The Lavipharm annual revenue was $8.3 million in 2026.
Telemaque Lavidas is the CEO of Lavipharm.
159 people are employed at Lavipharm.